US Patent 8003128 Polylactide nanoparticles
Patent 8003128 was granted and assigned to LTS Lohmann Therapie-Systeme AG on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+521 characters)
Article
Patent abstract
A drug targeting system for administering a pharmacologically active substance to the central nervous system of a mammal across the animal's blood brain barrier. The drug targeting system comprises nanoparticles made of poly(DL-lactide) and/or poly(DL-lactide-co-glycolide), a pharmacologically active substance which is absorbed to, adsorbed to, and/or incorporated into the nanoparticles, and either contains TPGS or comprises a pluronic 188 surfactant coating deposited on the drug-loaded nanoparticles.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08003128 Polylactide nanoparticles US Patent 8003128 Polylactide nanoparticles
Infobox
Patent Number
0800312800
Patent Number
800312800
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080031280
Date of Patent
August 23, 2011
0Patent Application Number
122255550
Date Filed
March 13, 2007
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080031280
Date of Patent
August 23, 2011
0Patent Application Number
122255550
Date Filed
March 13, 2007
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08003128 Polylactide nanoparticles
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08003128
Date of patent
August 23, 2011
Patent application number
12225555
Date Filed
March 13, 2007
Patent primary examiner
Find more entities like US Patent 8003128 Polylactide nanoparticles
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.